Parameter
| Biomarker | NID2 gene promoter methylation | Full name | Nidogen 2 gene promoter methylation | Molecular Type | Nucleic acid (DNA methylation) |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Early diagnosis (combinatorial detection) |
| Disease | Bladder Cancer (BC) | Disease Subtypes | / | ||
| Organ | Bladder | Test Sample / Technology Platform | Urine (qMSP, digital PCR) | ||
| Pathobiological Mechanisms | Promoter methylation occurs early; combined with ECRG4 & ITIH5 improves sensitivity & specificity | ||||
| Clinical Availability Status | Research verification stage | ||||
| Notes and Dynamics | Stand-alone sensitivity limited; included in methylation panels to boost combinatorial efficacy | ||||